BROWSE·page 59 of 257

Browse EX-10 agreements

3,074 matching material contract exhibits.


EX-10.3

Cabaletta Bio, Inc.

CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

AMENDMENTTOSERVICEAGREEMENT,July1,2026-November15,2027

CICandClientherebyagreetosupplementtheServiceAgreementasfollows:

Section1.License

NotwithstandingthefinalsentenceofSection1,thepartiesagreethatClientwillhavealicensetouseandoccupy the Space as provided in Section 2 below from July 1, 2026 - November 15, 2027 [the Term].

ThisSpace-SpecificAmendmentreplacestheamendmentsexecutedbyClientprevioustothesigningofthis document, which the parties agree is now null and void.

As this is a fixed term agreement, you will be responsible for payment of your fees for your term, even if you choosetovacateyourspacebeforetheendofyourterm.Exceptionstothismayonlybemadebymutualagreement in writing signed by both parties.

…

EX-10.3·10-Q·CIK 1759138·ACC 0001759138-26-000039·Filed Aug 13, 2026, 07:34 ET

EX-10.1

ABEONA THERAPEUTICS INC.

Certain confidential information contained in this document, marked by [***], has been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K because it is both (i) not material and (ii) the type of information that the registrant treats as private or confidential.

S15-479:IG EXCLUSIVE (EQUITY) AGREEMENT ** **

Execution Copy

EXCLUSIVE (EQUITY) AGREEMENT

This Exclusive (Equity) Agreement (“Agreement”) is entered into between THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (‘‘Stanford”), an institution of higher education having powers under the laws of the State of California, and Abeona Therapeutics Inc. (“Abeona”), a Delaware corporation, having a principal place of business at 1325 Avenue of the Americas, 27th Floor, New York, NY 10019. is effective on the 3rd day of August, 2016 (“Effective Date”).

1. BACKGROUND

…

EX-10.1·10-Q·CIK 318306·ACC 0001493152-26-037576·Filed Aug 13, 2026, 07:30 ET

EX-10.5

Pelthos Therapeutics Inc.

PELTHOS THERAPEUTICS INC.

2023 Equity Incentive Plan

Performance Stock Unit Agreement

This Performance Stock Unit Agreement and the associated grant award information (the “Customizing Information”), which Customizing Information is provided in written form (the “Performance Stock Unit Schedule”) or is available in electronic form from the record keeper for the Pelthos Therapeutics Inc. 2023 Equity Incentive Plan, as amended and restated and in effect from time to time (the “Plan”), made as of the date shown as the “Grant Date” in the Customizing Information (the “Grant Date”) by and between Pelthos Therapeutics Inc., a Nevada corporation (the “Company”), and the individual identified in the Customizing Information (the “Recipient”). This instrument and the Customizing Information are collectively referred to as the “Performance Stock Unit Agreement.”

WITNESSETH THAT:

WHEREAS, the Company has instituted the Plan; and

…

EX-10.5·10-Q·CIK 1919246·ACC 0001919246-26-000113·Filed Aug 13, 2026, 07:20 ET

EX-10.1

Zenas BioPharma, Inc.

ZENAS BIOPHARMA, INC.

2024 EMPLOYEE STOCK PURCHASE PLAN**
****(AMENDED AND RESTATED ON MAY 18, 2026)**

1. Defined Terms

Exhibit A, which is incorporated by reference, defines the terms used in this Plan and sets forth certain operational rules related to those terms.

2. Purpose of Plan

(a)Purpose. This Plan is intended to enable Eligible Employees to purchase shares of Stock in offerings under this Plan, and thereby acquire an interest in the Company. This Plan is intended to be exempt from the application and requirements of Section 409A of the Code, and is to be construed accordingly.

…

EX-10.1·10-Q·CIK 1953926·ACC 0001104659-26-095448·Filed Aug 13, 2026, 07:15 ET

EXHIBIT 10.1

BK Technologies Corp

INDEMNIFICATION AGREEMENT

**THIS AGREEMENT **is made this _______ day of __________, 20___, by and between BK Technologies Corporation, a Nevada corporation (the “Corporation”), and _______________________ (the “Director and/or Officer”).

**WHEREAS, the Director and/or Officer has agreed to serve, or continue to serve, as a director and/or officer of the Corporation or as a director, officer, trustee, manager, participating member and/or in any other similar capacity of an Other Entity (as defined below) (any one or more of which capacities constitute an “Indemnified Capacity”), **providing that adequate liability insurance, indemnification or a combination thereof is, and will continue to be, provided;

**WHEREAS, **the Corporation, in order to induce the Director and/or Officer to serve or continue to serve the Corporation and/or an Other Entity, has agreed to execute this Agreement to evidence the indemnification of the Director and/or Officer to the fullest extent permitted by law; and

…

EX-10.1·10-Q·CIK 2186·ACC 0001437749-26-027476·Filed Aug 13, 2026, 07:11 ET

EX-10.5

Venu Holding Corp

VENUE LEASE AGREEMENT

** **

**THIS VENUE LEASE AGREEMENT **(“Lease”) is made and entered into as of May 11, 2026 (the “Effective Date”) by and between **Sunset Amphitheater, LLC **a Colorado limited liability company whose address is 1755 Telstar Drive, Suite 501, Colorado Springs, CO 80920, herein designated as the “Landlord,” and **Notes Live Foundation, **a Colorado non-profit corporation, whose address 1755 Telstar Drive, Suite 501, Colorado Springs, CO 80920 d/b/a Venu Arts & Culture Foundation (“Foundation”), and Sunset Operations, LLC, a Colorado limited liability company, whose address is 1755 Telstar Drive, Suite 501, Colorado Springs, CO 80920 (“Sunset,” collectively with Foundation, the “Tenants”).

WITNESSETH:

** **

In consideration of the rent to be paid and the covenants to be performed by Tenants hereunder, Landlord does hereby lease and demise to Tenants, and Tenants do hereby lease and take from Landlord, the Premises described below, upon the following terms and conditions:

…

EX-10.5·10-Q·CIK 1770501·ACC 0001493152-26-037568·Filed Aug 13, 2026, 07:10 ET

EX-10.6

Venu Holding Corp

LEASE AGREEMENT

THIS LEASE AGREEMENT (this “Agreement”) dated this 11th day of May, 2026 (the “Effective Date”), is by and between Notes Live Foundation, a Colorado non-profit corporation d/b/a Venu Arts & Culture Foundation (“Foundation”) and Sunset Operations, LLC, a Colorado limited liability company (“Sunset”, collectively with Foundation, the “Landlords”) and AEG Presents – Rocky Mountains, LLC, a Delaware limited liability company (“Tenant”).

RECITALS

…

EX-10.6·10-Q·CIK 1770501·ACC 0001493152-26-037568·Filed Aug 13, 2026, 07:10 ET

EX-10.1

Aveanna Healthcare Holdings, Inc.

THIRTEENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT

THIRTEENTH AMENDMENT TO FIRST LIEN CREDIT AGREEMENT, dated as of May 26, 2026 (this “Amendment”), by and among AVEANNA HEALTHCARE LLC, a Delaware limited liability company (the “Borrower”), AVEANNA HEALTHCARE INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), the other Credit Parties party hereto, each 2026 Refinancing Term Loan Lender (as defined below) party hereto, each 2026 Refinancing Revolving Credit Lender (as defined below) party hereto, each L/C Issuer party hereto (the “L/C Issuers”) and BARCLAYS BANK PLC, as the Administrative Agent (in such capacity, the “Administrative Agent”) and as the Swingline Lender.

RECITALS:

…

EX-10.1·10-Q·CIK 1832332·ACC 0001193125-26-347842·Filed Aug 13, 2026, 07:00 ET

EX-10.2

Aveanna Healthcare Holdings, Inc.

EXECUTION VERSION

EIGHTH AMENDMENT TO THE

RECEIVABLES FINANCING AGREEMENT

This EIGHTH AMENDMENT TO THE RECEIVABLES FINANCING AGREEMENT (this “Amendment”), dated as of June 25, 2026, is entered into by and among the following parties:

(i)

AVEANNA SPV I, LLC, as Borrower;

(ii)

AVEANNA HEALTHCARE LLC, as initial Servicer; and

(iii)

PNC BANK, NATIONAL ASSOCIATION (“PNC”), as Administrative Agent and a Lender.

Capitalized terms used but not otherwise defined herein (including such terms used above) have the respective meanings assigned thereto in the Receivables Financing Agreement described below.

BACKGROUND

A.

The parties hereto are parties to the Receivables Financing Agreement, dated as of November 12, 2021 (as amended, restated, supplemented or otherwise modified through the date hereof, the “Receivables Financing Agreement”).

B.

The parties hereto desire to amend the Receivables Financing Agreement as set forth herein.

…

EX-10.2·10-Q·CIK 1832332·ACC 0001193125-26-347842·Filed Aug 13, 2026, 07:00 ET

EX-10.3

Aebi Schmidt Holding AG

AEBI SCHMIDT GROUP

DIRECTOR RESTRICTED STOCK AWARD AGREEMENT

Dear #ParticipantName#,

This is an individual Award Agreement under the “Equity Incentive Plan Aebi Schmidt Group” (the “Plan”); capitalized terms not defined herein shall have the meaning assigned to such terms in Appendix 1 to the Plan.

We are very happy to confirm your grant of Restricted Stock (“RS”), subject to the terms and conditions of the Plan and the further individual details set out below:

…

EX-10.3·10-Q·CIK 2048519·ACC 0001628280-26-056462·Filed Aug 13, 2026, 07:00 ET

EX-10.4

Aebi Schmidt Holding AG

AEBI SCHMIDT GROUP

RESTRICTED STOCK UNIT AWARD AGREEMENT

Dear #ParticipantName#,

This is an individual Award Agreement under the “Equity Incentive Plan Aebi Schmidt Group” (the “Plan”); capitalized terms not defined herein shall have the meaning assigned to such terms in Appendix 1 to the Plan.

We are very happy to confirm that the Board has decided to offer to you a grant of Restricted Stock Units (“RSUs”), subject to the terms and conditions of the Plan and the further individual details set out below:

…

EX-10.4·10-Q·CIK 2048519·ACC 0001628280-26-056462·Filed Aug 13, 2026, 07:00 ET

EX-10.2

Hepion Pharmaceuticals, Inc.

EX-10.2·10-Q·CIK 1583771·ACC 0001493152-26-037562·Filed Aug 13, 2026, 06:58 ET